Regarding the Jan. 11 editorial “What's behind the out-of-pocket cost problem," it is important to understand that the “out-of-pocket cost problem” does not affect all people equally. Those with life-threatening, chronic and rare diseases who require specialty medications are disproportionately burdened by high out-of-pocket costs. Unfortunately, this is often people on Medicare, many of whom do not qualify for low-income subsidies but also cannot afford the cost-sharing required by Medicare Part D.
Daniel Klein
President and CEOPatient Access Network FoundationWashington